<div id="readability-page-1"><div>SAN DIEGO, CA / ACCESS Newswire / February 11, 2026 / Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Picard Medical, Inc. (NYSE:PMI) securities between September 2, 2025 and October 31, 2025. Picard Medical claims to engage in designing, manufacturing, production, supply, marketing, and sale of medical device products.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.What are the allegations? Robbins LLP is Investigating Allegations that Picard Medical, Inc. (PMI) was the Subject of a Fraudulent Stock Promotion SchemeAccording to the complaint, defendants failed to disclose to investors: (1) that Picard was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; and (3) that Picard's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price.On October 24, 2025, Picard's stock price abruptly crashed 70%, to $3.99 per share. Since then, the Company's share price has continued to decline to approximately $2.00 per share.What can shareholders do now? You may be eligible to participate in the class action against Picard Medical, Inc. Shareholders, who wish to serve as lead plaintiff for the class must file their papers with the court by April 3, 2026. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.All representation is on a contingency fee basis. Shareholders pay no fees or expenses.About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.To be notified if a class action against Picard Medical, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.Attorney Advertising. Past results do not guarantee a similar outcome.Contact:Aaron Dumas, Jr.Robbins LLP5060 Shoreham Pl., Ste. 300San Diego, CA 92122adumas@robbinsllp.com(800) 350-6003www.robbinsllp.comSOURCE: Robbins LLPView the original press release on ACCESS Newswire</div></div>

SBIO

Robbins LLP has announced a class action lawsuit for shareholders of Picard Medical, Inc. (NYSE:PMI) who purchased shares between September 2, 2025, and October 31, 2025. The lawsuit alleges that PMI was involved in a fraudulent stock promotion scheme, leading to a 70% drop in stock price on October 24, 2025. Shareholders can file to be lead plaintiffs by April 3, 2026, and representation is on a contingency fee basis. Robbins LLP specializes in shareholder rights litigation.

Acceswire

iShares US Medical Devices

ALPS Medical Breakthrough

First Trust NYSE Arca Biotech Index Fd

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

Picard Medical

SPDR S&P Biotech

VanEck Biotech ETF

Proshares Ultra Nasdaq Biotech

Direxion S&P Biotech Bear 3X

SPDR S&P Health Equip

Shareholders Who Lost Money in Picard Medical, Inc. Should Contact Robbins LLP for Information About Leading the Class Action Against PMI